Literature DB >> 16230412

Ionizing radiation activates late herpes simplex virus 1 promoters via the p38 pathway in tumors treated with oncolytic viruses.

James J Mezhir1, Sunil J Advani, Kerrington D Smith, Thomas E Darga, Alice P W Poon, Hank Schmidt, Mitchell C Posner, Bernard Roizman, Ralph R Weichselbaum.   

Abstract

Ionizing radiation potentiates the oncolytic activity of attenuated herpes simplex viruses in tumors exposed to irradiation at specific time intervals by inducing higher virus yields. Cell culture studies have shown that an attenuated virus lacking the viral gamma(1)34.5 genes underproduces late proteins whose synthesis depends on sustained synthesis of viral DNA. Here we report that ionizing radiation enhances gene expression from late viral promoters in transduced cells in the absence of other viral gene products. Consistent with this result, we show that in tumors infected with the attenuated virus, ionizing radiation increases 13.6-fold above baseline the gene expression from a late viral promoter as early as 2 hours after virus infection, an interval too short to account for viral DNA synthesis. The radiation-dependent up-regulation of late viral genes is mediated by the p38 pathway, inasmuch as the enhancement is abolished by p38 inhibitors or a p38 dominant-negative construct. The p38 pathway is not essential for wild-type virus gene expression. The results suggest that ionizing radiation up-regulates late promoters active in the course of viral DNA synthesis and provide a rationale for use of radiation to up-regulate cytotoxic genes introduced into tumor cells by viral vectors for cytoreductive therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16230412     DOI: 10.1158/0008-5472.CAN-05-1927

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

1.  Activated MEK suppresses activation of PKR and enables efficient replication and in vivo oncolysis by Deltagamma(1)34.5 mutants of herpes simplex virus 1.

Authors:  Kerrington D Smith; James J Mezhir; Kai Bickenbach; Jula Veerapong; Jean Charron; Mitchell C Posner; Bernard Roizman; Ralph R Weichselbaum
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

2.  Rationale and Design of a Phase 1 Clinical Trial to Evaluate HSV G207 Alone or with a Single Radiation Dose in Children with Progressive or Recurrent Malignant Supratentorial Brain Tumors.

Authors:  Alicia M Waters; James M Johnston; Alyssa T Reddy; John Fiveash; Avi Madan-Swain; Kara Kachurak; Asim K Bag; G Yancey Gillespie; James M Markert; Gregory K Friedman
Journal:  Hum Gene Ther Clin Dev       Date:  2017-03       Impact factor: 5.032

Review 3.  The roles of viruses in brain tumor initiation and oncomodulation.

Authors:  Alexander Kofman; Lucasz Marcinkiewicz; Evan Dupart; Anton Lyshchev; Boris Martynov; Anatolii Ryndin; Elena Kotelevskaya; Jay Brown; David Schiff; Roger Abounader
Journal:  J Neurooncol       Date:  2011-07-01       Impact factor: 4.130

Review 4.  Combinatorial strategies for oncolytic herpes simplex virus therapy of brain tumors.

Authors:  Ryuichi Kanai; Samuel D Rabkin
Journal:  CNS Oncol       Date:  2013-03

5.  Construction and properties of a herpes simplex virus 1 designed to enter cells solely via the IL-13alpha2 receptor.

Authors:  Guoying Zhou; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-22       Impact factor: 11.205

Review 6.  Herpes simplex virus oncolytic therapy for pediatric malignancies.

Authors:  Gregory K Friedman; Joseph G Pressey; Alyssa T Reddy; James M Markert; G Yancey Gillespie
Journal:  Mol Ther       Date:  2009-04-14       Impact factor: 11.454

7.  Increased oncolytic efficacy for high-grade gliomas by optimal integration of ionizing radiation into the replicative cycle of HSV-1.

Authors:  S J Advani; J M Markert; R F Sood; S Samuel; G Y Gillespie; M Y Shao; B Roizman; R R Weichselbaum
Journal:  Gene Ther       Date:  2011-05-05       Impact factor: 5.250

8.  Herpesvirus vectors for therapy of brain tumors.

Authors:  Kevin A Cassady; Jacqueline Nuss Parker
Journal:  Open Virol J       Date:  2010-06-18

9.  Tumor radiosensitization by monomethyl auristatin E: mechanism of action and targeted delivery.

Authors:  Lisa Buckel; Elamprakash N Savariar; Jessica L Crisp; Karra A Jones; Angel M Hicks; Daniel J Scanderbeg; Quyen T Nguyen; Jason K Sicklick; Andrew M Lowy; Roger Y Tsien; Sunil J Advani
Journal:  Cancer Res       Date:  2015-02-13       Impact factor: 12.701

10.  Pediatric glioma stem cells: biologic strategies for oncolytic HSV virotherapy.

Authors:  Gregory K Friedman; Joel Raborn; Virginia M Kelly; Kevin A Cassady; James M Markert; G Yancey Gillespie
Journal:  Front Oncol       Date:  2013-02-28       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.